secwatch.observer — SEC 8-K summary
======================================

Issuer:     Skye Bioscience, Inc. (SKYE)
CIK:        0001516551
Form:       8-K
Filed at:   2021-09-15T23:59:59+00:00
Accession:  0001628280-21-018623
Event type: leadership
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Skye Bioscience terminates RoseRyan; Principal Accounting Officer Janney resigns
--------------------------------------------------------------------------------

- Terminated RoseRyan engagement as of Sept 14, 2021; Richard Janney resigned as Principal Accounting Officer.
- CEO Punit Dhillon will serve as principal accounting officer until successor is appointed.
- Company moved to new office at 11250 El Camino Real, San Diego, leasing approx. 2,645 sq ft from ROIC California.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1516551/000162828021018623/0001628280-21-018623-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1516551/000162828021018623/skye-20210914.htm
  HTML page:      https://secwatch.observer/filing/0001628280-21-018623

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer